TWC
AZN icon

TD Waterhouse Canada’s AstraZeneca AZN Stock Holding History

TD Waterhouse Canada’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.4M Buy
137,551
+1,974
+1% +$371K 0.07% 173
2026
Q1 		$27.1M Buy
135,577
+121,376
+855% +$23.4M 0.08% 158
2025
Q4 		$2.61M Buy
14,201
+12,239
+624% +$2.15M 0.02% 402
2025
Q3 		$331K Buy
1,962
+331
+20% +$50.1K ﹤0.01% 769
2025
Q2 		$233K Sell
1,631
-167
-9% -$23.4K ﹤0.01% 798
2025
Q1 		$261K Sell
1,798
-5,948
-77% -$861K ﹤0.01% 745
2024
Q4 		$1.01M Buy
7,746
+1,651
+27% +$231K 0.01% 512
2024
Q3 		$958K Buy
6,095
+659
+12% +$106K 0.01% 503
2024
Q2 		$849K Buy
5,436
+158
+3% +$23.8K 0.01% 506
2024
Q1 		$786K Buy
+5,278
New +$699K 0.01% 541

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

TD Waterhouse Canada's AZN Position: Q2 2026 in Review

TD Waterhouse Canada increased its AstraZeneca (AZN) stake by 1.5% in Q2 2026, buying an estimated $371K and bringing the position to 137,551 shares worth $25.4M. The position accounts for 0.07% of the portfolio, ranked #173.

TD Waterhouse Canada first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $27.1M in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • TD Waterhouse Canada held 137,551 shares of AstraZeneca worth $25.4M as of Q2 2026.
  • TD Waterhouse Canada bought 1,974 AstraZeneca shares in Q2 2026, an estimated $371K.
  • AstraZeneca made up 0.07% of TD Waterhouse Canada's portfolio in Q2 2026, its #173 holding.
  • TD Waterhouse Canada first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
  • TD Waterhouse Canada's AstraZeneca position peaked at $27.1M in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.